Using the new, granular datapoints in Pharmaprojects, Senior Director Ian Lloyd presents his expert insights into pharma’s R&D activities over the past year and what they may mean for the pipeline during the year to come. The 27th instalment of the Annual Review, this version takes advantage of improvements to Pharmaprojects’ data granularity to bring you details on pharma R&D trends. Go deeply into the pipeline by company, therapeutic area, disease, target, and drug type for insights into the direction R&D is heading as we move into an exciting new decade.

Complete the form to download your free whitepaper!

First Name*

Last Name*

Company*

Job Title*

Email Address*

Country*

Business Phone*

Informa Marketing Opt In

By ticking this box, you agree to receive emails such as relevant news, updates and offers from Informa Business Intelligence, and carefully selected similar products from our portfolio

Third Party Marketing Opt in

By ticking this box, you agree to receive emails such as promotional offers from other members of the Informa group and selected 3rd party companies

Informa Business Intelligence